Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	13.43B -7.3%
Revenue (ttm)	630.37M +25.6%
Net Income	200.19M +36.8%
EPS	1.46 +36.4%
Shares Out	137.75M
PE Ratio	66.79
Forward PE	49.25
Dividend	0.80 (0.82%)
Ex-Dividend Date	May 29, 2025

Volume	337,710
Average Volume	341,077
Open	100.83
Previous Close	100.48
Day's Range	97.44 - 100.92
52-Week Range	95.28 - 132.94
Beta	0.25
RSI	28.57
Earnings Date	Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2025, SHA:688198's revenue was 630.37 million, an increase of 25.60% compared to the previous year's 501.88 million. Earnings were 200.19 million, an increase of 36.81%.